Add BrightSurf on Google Email

Science News Archive February 2025


Page 1 of 44

Brain network disorders review uncovers the link between metabolic disorders and Alzheimer's disease

Researchers explore the connection between Alzheimer's and metabolic syndrome, finding links between insulin regulation, high blood pressure, and obesity. The study suggests that maintaining healthy blood fat levels may be crucial for brain health, paving way for potential therapeutic developments.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateFeb 18, 2025

How do the universe’s highest-energy particles originate? Magnetic outflows stemming from star mergers, analysis concludes

New York University physicist Glennys Farrar introduces a theory explaining the origin of Ultrahigh Energy Cosmic Rays, created through Binary Neutron Star mergers. This process generates powerful magnetic outflows and gravitational waves, providing a groundbreaking tool for understanding cataclysmic events.

SourceNew York University·JournalPhysical Review Letters·DateFeb 28, 2025

Need a business plan? Ask AI

A new study from the University of Texas at Austin finds that AI can create high-quality business plans and even critique existing strategies. The research suggests that AI can enhance the speed, quality, and scale of strategic decision-making, potentially giving companies a competitive edge and enhancing performance.

SourceUniversity of Texas at Austin·JournalStrategy Science·DateFeb 28, 2025

Rice researchers develop efficient lithium extraction method, setting stage for sustainable EV battery supply chains

Researchers from Rice University have developed an efficient lithium extraction method using solid-state electrolyte membranes, which can separate lithium from water and other ions with near-perfect selectivity. This breakthrough could make the production of EV batteries more sustainable by reducing reliance on traditional mining methods.

SourceRice University·JournalScience Advances·DateFeb 28, 2025

An unexpected insight into Alzheimer’s disease

A unique case study reveals an unexpected discrepancy between Alzheimer's pathology and cognitive function in a woman with Down syndrome. The study highlights the need to expand inclusion criteria for therapeutic drug trials and uncover genetic or lifestyle factors that contribute to cognitive preservation.

SourceUniversity of Pittsburgh·JournalAlzheimer s & Dementia·TypeCase study·DateFeb 28, 2025

Call for Vietnam low-emission food system reforms

Researchers highlight the need for policymakers to learn from existing multistakeholder forums and implement 'real-world' changes to reduce greenhouse gas emissions and promote equity in Vietnam's food systems. The study suggests a holistic, cross-sectoral approach is necessary to address the issue.

SourceFlinders University·JournalWorld Development Perspectives·TypeNews article·DateFeb 28, 2025

Micro-expression detection in ASD movies: a YOLOv8-SMART approach

Researchers developed an AI-driven approach to detect micro-expressions in ASD movies, achieving remarkable improvements in recognition accuracy. This innovative method provides clinicians with an objective tool to detect subtle emotional cues, enabling earlier and more accurate diagnoses.

SourceELSP·JournalBiomedical Informatics·TypeData/statistical analysis·DateFeb 28, 2025

Cholesterol drug repurposed as investigational therapy for HPV+ cancers at University Hospitals Seidman Cancer Center in nation’s first-ever clinical trials

Researchers at University Hospitals Seidman Cancer Center have successfully repurposed fenofibrate, a cholesterol drug, to treat HPV+ cancers. The study found that fenofibrate restores the function of key tumor suppressor gene p53 and reactivates immune cells, offering a potential targeted therapy for these cancers.

Illinois researchers develop next-generation organic nanozymes and point-of-use system for food and agricultural uses

The University of Illinois researchers have developed organic-material-based nanozymes that can detect histamine in food products with an affordable analytic performance profile. An integrated point-of-use platform allows for rapid detection of agricultural and biological molecules without laboratory equipment.

Hepatic biliary adenofibroma: Histological characteristics, diagnostic challenges, and its role as a precursor to intrahepatic cholangiocarcinoma

Hepatic biliary adenofibroma (BAF) is a rare, benign tumor with histological characteristics distinct from other biliary tumors. Emerging case reports suggest potential for malignant transformation and overlap with intrahepatic cholangiocarcinoma (iCCA), highlighting diagnostic challenges and need for further research.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Pathology·DateFeb 28, 2025

TTUHSC conducting study to help patients that experience traumatic blood loss

The Texas Tech University Health Sciences Center is conducting a randomized controlled trial to investigate the effectiveness of calcium and vasopressin in treating severely injured patients who experience significant blood loss. The study, known as CAVALIER, will enroll approximately 1,050 participants aged 18-90.

SourceTexas Tech University Health Sciences Center·TypeRandomized controlled/clinical trial·DateFeb 28, 2025

Ursodeoxycholic acid for the management of drug-induced liver injury: Role of hepatoprotective and anti-cholestatic mechanisms

Ursodeoxycholic acid (UDCA) exhibits a broad range of hepatoprotective mechanisms, including antioxidant, anti-inflammatory, and anti-apoptotic properties, which may benefit various types of drug-induced liver injury. In hepatocellular DILI, UDCA reduces inflammation, alleviates ER stress, and protects against mitochondrial damage. In ...

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateFeb 28, 2025

After NIH decision to cap indirect costs, prominent molecular biologist calls for swift action, petition signatures

Tom Maniatis, a prominent molecular biologist, is warning of the impact of the NIH's planned 15% cap on indirect costs. He believes small independent institutions will be harmed, stifling technological innovation and scientific progress. The scientific community must act swiftly to prevent this from happening.

SourceCell Press·JournalCell·TypeCommentary/editorial·DateFeb 28, 2025